IUI and IVF with donor sperm (from a sperm bank)
|
|
Donor sperm is used when the semen of the male partner contains no spermatozoa (azoospermia), in case of illness, if he is a carrier of a serious genetic or infectious disease, etc.
The Gynaecology & Fertility Centre cooperates with certified sperm banks abroad, which meet strict criteria in terms of the safety and effectiveness of the genetic material provided.
Donor Screening
Initially the donors are selected based on a number of parameters:
• Sperm Quality
• Age
• Personality
• Education
• 4 Generation Family Health History
Further screening includes blood and urine analysis:
• Chemistry Panel
• Complete Blood Count
• Urinalysis
• ABO-Rh Blood typing
• HIV
• HTLV I/II
• Hepatitis B Surface Antigen
• Hepatitis B Core Antibody
• Hepatitis C Viral Antibody
• Syphilis (RPR)
• CMV IgG/IgM
• Chlamydia
• Gonorrheae
The genetic tests include the following:
• 4 generation family medical history, which is reviewed by a trained genetic specialist or a medical doctor (all donors)
• Cystic Fibrosis screening for 32-86 mutations in the Cystic Fibrosis gene (all Caucasian donors)
• Chromosome analysis (all donors)
• Thalassemia (all donors). An HPLC analysis is done to detect this indirectly. Please contact us if you would like to have your donor genetically screened for carrier status.
• Tay-Sachs disease (donors with Ashkenazi Jewish or French Canadian ancestry)
• Canavan disease disease (donors with Ashkenazi Jewish ancestry)
• Familial Dysautonomia (donors with Ashkenazi Jewish ancestry)
• Fanconi Anemia type C (donors with Ashkenazi Jewish ancestry)
• Gaucher disease (donors with Ashkenazi Jewish ancestry)
• Niemann-Pick type A disease (donors with Ashkenazi Jewish ancestry)
• Sickle Cell Disease (donors with African ancestry are genetically screened). For all donors an HPLC analysis is done to detect this indirectly.
• Canavan disease (donors with Ashkenazi Jewish ancestry)
News
After 16 years of trying to have a baby, our dream became reality!
Irini - Babis
Edessa 25/1/2012
